For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Hookipa Pharma Inc’s stock clocked out at $0.71, down -3.55% from its previous closing price of $0.73. In other words, the price has decreased by $-3.55 from its previous closing price. On the day, 0.85 million shares were traded. HOOK stock price reached its highest trading level at $0.75 during the session, while it also had its lowest trading level at $0.7.
Ratios:
To gain a deeper understanding of HOOK’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.50 and its Current Ratio is at 3.50. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.04.
Morgan Stanley Downgraded its Overweight to Equal-Weight on November 12, 2021, while the target price for the stock was maintained at $6.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 21 ’23 when Kandera Reinhard bought 7,000 shares for $0.72 per share. The transaction valued at 5,075 led to the insider holds 43,092 shares of the business.
Kandera Reinhard bought 8,000 shares of HOOK for $5,712 on Aug 16 ’23. The Chief Financial Officer now owns 36,092 shares after completing the transaction at $0.71 per share. On Jul 11 ’23, another insider, Aldag Jorn, who serves as the Chief Executive Officer of the company, bought 5,000 shares for $0.83 each. As a result, the insider paid 4,142 and bolstered with 71,952 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOOK now has a Market Capitalization of 69957720 and an Enterprise Value of -40579276. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.48 while its Price-to-Book (P/B) ratio in mrq is 0.78. Its current Enterprise Value per Revenue stands at -2.016 whereas that against EBITDA is 0.499.
Stock Price History:
The Beta on a monthly basis for HOOK is 0.97, which has changed by -0.256572 over the last 52 weeks, in comparison to a change of 0.23061275 over the same period for the S&P500. Over the past 52 weeks, HOOK has reached a high of $2.05, while it has fallen to a 52-week low of $0.41. The 50-Day Moving Average of the stock is -3.66%, while the 200-Day Moving Average is calculated to be 5.25%.
Shares Statistics:
It appears that HOOK traded 541.86K shares on average per day over the past three months and 574260 shares per day over the past ten days. A total of 96.55M shares are outstanding, with a floating share count of 70.40M. Insiders hold about 28.85% of the company’s shares, while institutions hold 35.34% stake in the company. Shares short for HOOK as of 1711584000 were 315905 with a Short Ratio of 0.58, compared to 1709164800 on 299465. Therefore, it implies a Short% of Shares Outstanding of 315905 and a Short% of Float of 0.33000002.
Earnings Estimates
The current assessment of Hookipa Pharma Inc (HOOK) involves the perspectives of 4 analysts closely monitoring its market dynamics.On average, analysts expect EPS of $-0.1 for the current quarter, with a high estimate of $-0.04 and a low estimate of $-0.18, while EPS last year was $-0.27. The consensus estimate for the next quarter is $-0.05, with high estimates of $0.05 and low estimates of $-0.13.
Analysts are recommending an EPS of between $-0.04 and $-0.6 for the fiscal current year, implying an average EPS of $-0.36. EPS for the following year is $-0.51, with 4 analysts recommending between $-0.37 and $-0.72.
Revenue Estimates
In the current quarter, 3 analysts expect revenue to total $2.8M. It ranges from a high estimate of $4M to a low estimate of $2M. As of the current estimate, Hookipa Pharma Inc’s year-ago sales were $4.39M, an estimated decrease of -36.20% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $10.47M, an increase of 290.80% over than the figure of $-36.20% in the same quarter last year. There is a high estimate of $25M for the next quarter, whereas the lowest estimate is $2M.
A total of 3 analysts have provided revenue estimates for HOOK’s current fiscal year. The highest revenue estimate was $72.5M, while the lowest revenue estimate was $8M, resulting in an average revenue estimate of $32.9M. In the same quarter a year ago, actual revenue was $20.13M, up 63.40% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $14.93M in the next fiscal year. The high estimate is $25M and the low estimate is $7.89M. The average revenue growth estimate for next year is down -54.60% from the average revenue estimate for this year.
